| No. of event / No. of total (%) | Follow-up duration (PY) | Incidence rate per 1000 (PY) | Incidence rate difference (95% CI) | Hazard ratios (95% CI) | |||
---|---|---|---|---|---|---|---|---|
Crude | P-value | Overlap weighted modela | P-value | |||||
Migraine and control group (n = 226,230) | ||||||||
 Migraine | 4,216 / 45,246 (9.3) | 411,173 | 10.25 | 2.61 (2.30 to 2.92) | 1.34 (1.30–1.39) | < 0.001* | 1.35 (1.31–1.39) | < 0.001* |
 Control | 12,549 / 180,984 (6.9) | 1,642,298 | 7.64 |  | 1 |  | 1 |  |
Migraine with aura and control group (n = 16,815) | ||||||||
 Migraine with aura | 352 / 3,363 (10.5) | 33,193 | 10.60 | 3.89 (2.85 to 4.93) | 1.58 (1.40–1.79) | < 0.001* | 1.38 (1.29–1.48) | < 0.001* |
 Control | 898 / 13,452 (6.7) | 133,709 | 6.72 |  | 1 |  | 1 |  |
Migraine without aura and control group (n = 209,414) | ||||||||
 Migraine without aura | 3,864 / 41,883 (9.2) | 377,967 | 10.22 | 2.50 (2.18 to 2.82) | 1.32 (1.28–1.37) | < 0.001* | 1.28 (1.24–1.32) | < 0.001* |
 Control | 11,651 / 167,532 (7.0) | 1,508,589 | 7.72 |  | 1 |  | 1 |  |